Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

16.00
+3.50
+(28.00%)
At close: April 23 at 2:50:04 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John Bernard Payne President, CEO & Chairman of the Board 400k -- 1948
Mr. Keith R. Marchiando CFO, Treasurer & Secretary 312k -- 1962
Dr. Harlan L. Miller III Vice President of Technology & Global Supply -- -- --

ZIVO Bioscience, Inc.

2125 Butterfield Drive
Suite 100
Troy, MI 48084
United States
248 452 9866 https://www.zivobioscience.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
7

Description

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Corporate Governance

ZIVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 8:00 PM UTC - May 16, 2025 at 8:00 PM UTC

ZIVO Bioscience, Inc. Earnings Date

Recent Events

March 18, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 15, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 7, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 18, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers